Clenbuterol plasma pharmacokinetics in cattle†

Abstract

The pharmacokinetics of clenbuterol (Cb) were investigated to determine the extent to which analysis of plasma concentration can be used to discriminate between therapeutic and illicit growth promoting treatment of cattle. Analysis of plasma concentration enabled assessment of the extent of differences in pharmacokinetics between such dosing regimens. Cattle were treated with Cb using either a therapeutic (20 calves, 0.8 µg Cb kg^–1, twice daily in feed for 10 days), or growth promoting (30 calves, 10 µg Cb kg^–1, twice daily by drench for 20 days) dosing regimens. Blood samples were collected by jugular venepuncture, and plasma Cb concentrations determined by direct enzyme immunoassay. To determine plasma pharmacokinetics, use of a two compartment model was applied to the data and revealed that steady state kinetics were reached after 3 and 5 days following initiation of therapeutic and growth promoting dosing regimens, respectively. Tolerance limit analysis of concentrations during the therapeutic regimen indicated that a plasma Cb concentration greater than 1.63 ng ml^–1 would be indicative (p < 0.01) of a growth promoting dose.

References

1. A. R. Peters, The veterinary record, April 22, 1989 and references cited therein.
2. G. Degand, Bernes-Duytckaerts and H. D. Short, Food Addit. Contam., 1992, 40, 70.
3. I. Yamamoto and K. Iwata, J. Immunoassay, 1982, 3(2), 155.
4. A. Blass, M. Dave, R. J. Fallon, J. C. Illera, M. Illera and M. Sauer, J. Vet. Pharmacol. Ther., submitted.
5. M. J. Sauer, R. J. H. Pickett, S. Limer and S. N. Dixon, J. Vet. Pharmacol. Ther., 1995, 18, 81.
6. B. Stoffel and H. H. D. Meyer, J. Anim. Sci., 1993, 71, 1875.
7. D. J. Morgan, Clin. Pharmacokinet., 1990, 18, 270.
8. R. F. Witkamp, Residues of Veterinary Drugs and Mycotoxins in Animal Products: New methods for risk assessment and quality control, Wageningen Pers., The Netherlands, 1996, p. 113.
9. S. D. Bucknall, A. L. Mackenzie, M. J. Sauer, D. J. Everest, R. Newman and R. Jackman, Anal. Chim. Acta, 1993, 275, 227.
10. M. J. Sauer, R. J. H. Pickett and A. L. Mackenzie, Anal. Chim. Acta, 1993, 275, 195.
11. P. C. Heinzel, R. Woloszaczak and P. Thomann, TopFit 2.0 Pharmacokinetic and Pharmacodynamic Data Analysis System, Version 2.0, Gustav Fischer Verlag, Stuttgart, Jena and New York, 1993.
12. M. G. Kendall and A. Stuart, The Advanced Theory of Statistics: Inference and relationships, Charles Griffin and Co. Ltd., London, ISBN 0852642156, 1973, vol. 2, 3rd edn., p. 133.
13. J. F. Martínez-Navarro, Lancet, 1990, 336, 1311.
14. C. Pulce, D. Lamaison, G. Keck, C. Bostvironnois, J. Nicolas and J. Descotes, J. Vet. Hum. Toxicol., 1991, 33, 480.
15. L. Salleras, A. Domínguez, E. Mata, J. L. Taberner, I. Moro and P. Salvà, Public Health Reports, 1995, 100(3), 338.